Bristol-Myers Squibb Company v FH Faulding & Co Ltd

Bristol-Myers Squibb Company, an American pharmaceutical corporation, commenced proceedings against FH Faulding & Co Ltd, an Australian pharmaceutical company, in the Federal Court of Australia. The dispute centred on the validity and scope of two petty patents held by FH Faulding, which were related to the production of pharmaceutical products. Bristol-Myers Squibb argued that the patents were invalid and that FH Faulding had misused its patent rights.

The court was required to determine several legal issues, including whether the patents in question were valid, whether they had been misused, and if Bristol-Myers Squibb's actions constituted an abuse of process. The court also needed to assess whether the patents were relevant to Bristol-Myers Squibb's activities and if FH Faulding's conduct was appropriate in the circumstances.

In delivering the judgment, the court found that the patents were valid and had not been misused. The court held that Bristol-Myers Squibb's application for revocation of the patents was an abuse of process because it was brought with improper motives and without a reasonable prospect of success. The court further found that FH Faulding's conduct in enforcing its patent rights was reasonable and appropriate. As a result, the court dismissed Bristol-Myers Squibb's application for revocation of the patents and ordered it to pay FH Faulding's costs. The court also revoked the patents in question as they were found to be invalid.